Wednesday, February 8, 2023
Market-Reporter
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
Market-Reporter
No Result
View All Result
Home U.S. Markets

Jubilant HollisterStier reaches deal to produce COVID-19 vaccine Covaxin for U.S., Canadian markets

MtR by MtR
June 16, 2021
in U.S. Markets
0
Jubilant HollisterStier reaches deal to produce COVID-19 vaccine Covaxin for U.S., Canadian markets


Spokane-based pharmaceuticals manufacturer Jubilant HollisterStier has reached a deal to produce a new COVID-19 vaccine candidate for U.S. and Canadian markets.

The company, a subsidiary of Jubilant Pharma Limited, has entered an agreement with Pennsylvania-based biopharmaceutical company Ocugen to manufacture Covaxin, a COVID-19 vaccine developed by Bharat Biotech in India, Jubilant announced Tuesday.

Ocugen is codeveloping Covaxin with Bharat Biotech for the U.S. market.

While the company had been seeking emergency use approval in the U.S., Ocugen announced last week the company has changed course and is seeking full approval at the recommendation of the U.S. Food and Drug Administration.

“Based on Bharat’s strong track record of developing and commercializing vaccines globally and Jubilant’s proven track record in manufacturing, we are well-prepared to transition U.S. manufacturing of Covaxin to our new partner,” J.P. Gabriel, senior vice president of manufacturing and supply chain for Ocugen, said in Tuesday’s announcement.

Ocugen previously announced discussions have started with Health Canada for regulatory approval after the company secured exclusive rights to market the vaccine in the country.

Jubilant HollisterStier is reportedly the only pharmaceutical manufacturer of COVID-19 vaccines and therapeutics in the state of Washington.

The company is producing the antiviral remdesivir and is working with American biotechnology company Novavax to provide fill-finish manufacturing services for the production of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax said Monday the vaccine demonstrated 90.4% overall efficacy in a recent clinical trial.

In March, Bharat Biotech announced Covaxin demonstrated 81% efficacy in a trial involving 25,800 subjects 18-98 years of age.

While Jubilant has said the company is producing other products related to COVID-19, company leaders have declined to disclose specific details to date, citing confidentiality agreements.

“We are excited to expand our basket of vaccine products and meet the increasing demand from our customers for COVID-19 vaccines in the U.S.,” Amit Arora, president of Jubilant HollisterStier, said in a statement.



Source link

Related articles

U.S. inflation CPI report, Wall Street, currencies

August 10, 2022

U.S. Stocks Holding On To Strong Gains After Early Rally

August 10, 2022

Related Posts

U.S. inflation CPI report, Wall Street, currencies

by MtR
August 10, 2022
0

SINGAPORE — Futures in Australia pointed to a lower open Thursday after a better-than-expected inflation report in the U.S. sent...

U.S. Stocks Holding On To Strong Gains After Early Rally

by MtR
August 10, 2022
0

(RTTNews) - After moving sharply higher early in the session, stocks continue to see significant strength in afternoon trading on...

Cooling Inflation Sends Stocks Soaring

by MtR
August 10, 2022
0

US stocks rallied Wednesday after data showed headline US inflation cooled in July.  The headline reading of 8.5% was below...

Analysis: China investors hedge U.S. delisting risk with Hong Kong play

by MtR
August 10, 2022
0

A floor trader walks during afternoon trading at the Hong Kong Stock Exchange in Hong Kong, China September 26, 2016....

Share Market Today LIVE | Sensex, Nifty, BSE, NSE, Share Prices, Stock Market News Updates 10 August

by MtR
August 10, 2022
0

Share Market News Today | Sensex, Nifty, Share Prices LIVE: Indian equity markets are likely to open lower amid weak...

Load More
  • Trending
  • Comments
  • Latest

Bank of England tells ministers to intervene on digital currency ‘programming’

June 21, 2021

Tips for checking smoke alarms during daylight saving time

March 12, 2022

GLOBAL MARKETS-U.S. stocks follow Europe up; Treasury yields rise, dollar firm

July 9, 2021

What will Durham County education bonds pay for? A full list

July 8, 2022
African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

0
Maxum Foods releases Global Dairy Commodity Update for June

Maxum Foods releases Global Dairy Commodity Update for June

0
Letter: Perpetual bonds can help states fight hunger

Letter: Perpetual bonds can help states fight hunger

0
United Kingdom ETFs Are Riding the Re-Opening Momentum

United Kingdom ETFs Are Riding the Re-Opening Momentum

0

Investment in overseas real estate surges : The DONG-A ILBO

August 11, 2022

U.S. inflation CPI report, Wall Street, currencies

August 10, 2022

Alberta oil production set new record in first half of 2022

August 10, 2022

Industrial Lubricants Market to Reach $71 Billion by 2027.

August 10, 2022

Recent News

Investment in overseas real estate surges : The DONG-A ILBO

August 11, 2022

U.S. inflation CPI report, Wall Street, currencies

August 10, 2022

Alberta oil production set new record in first half of 2022

August 10, 2022

Categories

  • Asia
  • Bonds
  • Canada
  • Commodities
  • Cryptocurrencies
  • Currencies
  • Emerging Markets
  • ETFs
  • Europe & Middle East
  • IPOs
  • Latin America
  • Mutual Funds
  • Personal Finance
  • Real Estate
  • Retirement
  • Spending & Saving
  • Stocks
  • U.S. Markets
  • Privacy & Policy
  • About Us
  • Contact Us
  • Advertise with us

© 2021 Copyright Market-Reporter

No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate

© 2021 Copyright Market-Reporter